Related Experiment Video
Updated: Apr 4, 2026
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
PI3K-AKT pathway polymerase chain reaction (PCR) array analysis of epilepsy induced by type II focal cortical
1Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Abstract:
The aims of this study were to observe the differential expression of PI3K-AKT pathway-related genes in seizure-inducing brain lesions in type II focal cortical dysplasia, and to explore the relationship between gene expression and histological changes in dysplastic foci and their epileptogenic mechanism. Typical lesions in brain tissue from three patients with epilepsy induced by type II focal cortical dysplasia were selected for analysis, along with normal brain tissue from two control group individuals. Following quantitative expression analysis using the RT2 Profiler(TM) PI3K-AKT PCR Array, differential expression of the pathway related genes was detected in the focal brain tissue lesions, and gene function queries were performed. Compared with the control group, thirteen related genes appeared to exhibit marked differences in expression in epileptic lesions from patients with type II focal cortical dysplasia; those genes were found to be involved in regulation of cell size, morphology, adhesion, migration, and apoptosis, and in immunity, inflammation, and many other domains. The differential expression of multiple genes in the PI3K-AKT signaling pathway in type II focal cortical dysplasia may be an important molecular mechanism underlying histological changes and recurrent seizures.
Insights
This study found thirteen PI3K-AKT pathway genes are differentially expressed in focal cortical dysplasia type II brain lesions. These gene expression changes may explain histological alterations and recurrent seizures in epilepsy.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Focal cortical dysplasia (FCD) type II is a malformation of cortical development associated with epilepsy.
- The PI3K-AKT signaling pathway plays a crucial role in cellular processes relevant to brain development and function.
- Understanding the molecular mechanisms underlying FCD type II is essential for developing targeted therapies.
Purpose of the Study:
- To investigate the differential expression of PI3K-AKT pathway-related genes in FCD type II brain lesions.
- To correlate gene expression patterns with histological changes in FCD type II.
- To elucidate the potential epileptogenic mechanisms involving the PI3K-AKT pathway in FCD type II.
Main Methods:
- Analysis of brain tissue samples from three patients with FCD type II-induced epilepsy and two controls.
- Quantitative gene expression analysis using the RT2 Profiler™ PI3K-AKT PCR Array.
- Functional annotation and pathway analysis of differentially expressed genes.
Main Results:
- Thirteen PI3K-AKT pathway-related genes showed significant differential expression in FCD type II lesions compared to controls.
- These genes are involved in critical cellular functions including cell size regulation, morphology, adhesion, migration, and apoptosis.
- Differential expression was also noted in genes related to immunity and inflammation.
Conclusions:
- The aberrant expression of multiple genes within the PI3K-AKT signaling pathway represents a potential molecular mechanism in FCD type II.
- These molecular alterations likely contribute to the observed histological changes and the generation of recurrent seizures.
- Targeting the PI3K-AKT pathway could offer novel therapeutic strategies for FCD type II-associated epilepsy.
